Laboratory Corporation of America Holdings
NYSE:LH
Net Margin
Laboratory Corporation of America Holdings
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.1B USD |
6%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
85.5B USD |
1%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
73.8B EUR |
2%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
84.9B USD |
2%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
29B EUR |
3%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.8B EUR |
2%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.4B USD |
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
14.5B EUR |
3%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
13.4B USD |
9%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.7B USD |
7%
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
12.8B AUD |
6%
|
Laboratory Corporation of America Holdings
Glance View
Laboratory Corporation of America Holdings, commonly known as LabCorp, stands as a formidable player in the world of healthcare diagnostics. Emerging from a confluence of scientific innovation and business acumen, LabCorp has carved a niche within the intricate fabric of healthcare services. Since its inception, the company has excelled in offering a comprehensive suite of laboratory-based tests and services, empowering physicians and healthcare providers with critical insights needed for effective patient diagnosis and management. With its headquarters in Burlington, North Carolina, LabCorp operates a vast network of laboratories and patient service centers across the nation, providing services that range from routine blood work to sophisticated genomic testing. The essence of LabCorp’s business model lies in seamless integration across the healthcare continuum, driving both operational efficiency and profitability. Fundamentally, the company generates revenue by performing diagnostic tests on patient specimens, serving hospitals, managed care organizations, physician offices, and governmental agencies. As healthcare systems evolve towards precision medicine, LabCorp has harnessed emerging technologies and innovations like genomic testing to enhance its service offerings. This expansion not only aligns with changing healthcare paradigms but also fortifies its market leadership. By continually investing in research and development, LabCorp keeps its services at the cutting edge, ensuring steady growth and resilience in an ever-changing healthcare landscape.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Laboratory Corporation of America Holdings's most recent financial statements, the company has Net Margin of 5.6%.
You don't have any saved screeners yet